Adaptation to chronic hypoxia confers tolerance to subsequent myocardial ischemia by increased nitric oxide production

Annals of the New York Academy of Sciences

Volumn 874, Issue , 1999, Pages 236-253

  Baker, John E ^a   Holman, Patricia ^a   Kalyanaraman, B ^a   Griffith, Owen W ^a   Pritchard Jr , Kirkwood A ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC GMP; N(G) NITROARGININE METHYL ESTER; NITRATE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE; POTASSIUM; POTASSIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; CYANOTIC HEART DISEASE; ENZYME ACTIVITY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HYPOXIA; NONHUMAN; RABBIT;

EID: 0032773216     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb09239.x     Document Type: Conference Paper

References (38)

1. 1. TUCKER, W.Y., K. TURLEY, D.J. ULLYOT et al. 1979. Management of symptomatic tetralogy of Fallot in the first year of life. J. Thorac. Cardiovasc. Surg, 78: 494-501.
2. 2. GUSTAFSON, R.A., G.F. MURRAY, H.E. WARDEN et al. 1988. Early primary repair of tetralogy of Fallot. Ann. Thorac. Surg. 45: 235-241.
3. 3. TOUATI, G.D., P.R. VOUHE, A. AMODEO et al. 1990. Primary repair of tetralogy of Fallot in infancy. J. Thorac. Cardiovasc. Surg. 99: 396-403.
4. 4. GROH, M.A., J.N. MELIONES, E.L. BOVE et al. 1991. Repair of tetralogy of Fallot in infancy: effect of pulmonary artery size on outcome. Circulation 84(Suppl): III206-212.
5. 5. KIRKLIN, J.W., E.H. BLACKSTONE, R.A. JONAS et al. 1992. Morphologic and surgical determinants of outcome events after repair of tetralogy of Fallot and pulmonary stenosis: a two-institution study. J. Thorac. Cardiovasc. Surg. 103: 706-723.
6. 6. DI DONATO, R.M., R.A. JONAS, P. LANGS et al. 1991. Neonatal repair of tetralogy of Fallot with and without pulmonary atresia. J. Thorac. Cardiovasc. Surg. 101: 126-137.
7. 7. UVA, M.S., F. LACOUR-GAYET, T. KOMIYA et al. 1994. Surgery for tetralogy of Fallot at less than six months of age. J. Thorac. Cardiovasc. Surg. 107: 1291-1300.
8. 8. BAKER, E.J., L.E. BOERBOOM, G.N. OLINGER et al. 1995. Tolerance of the developing heart to ischemia. Impact of hypoxemia from birth. Am. J. Physiol. 268: H1165-H1173.
9. 9. SHAUL, P.W., A.J. NORTH, T.S. BRANNON et al. 1995. Prolonged in vivo hypoxia enhances nitric oxide synthase type I and type II gene expression in adult rat lung. Am. J. Respir. Cell Mol. Biol. 13: 167-174.
10. 10. RESTA, T.C., R.J. GONZALES, W.G. DAII. et al. 1997. Selective upregulation of arterial endothelial nitric oxide synthase in pulmonary hypertension. Am. J. Physiol. 272: H806-H813.
11. 11. LE CRAS, T.D., C. XUE, A. RENGASAMY et al. 1996. Chronic hypoxia upregulates endothelial and inducible NO synthase gene and protein expression in rat lung. Am. J. Physiol. 270: L164-L170.
12. 12. KONOREV, E.A., J. JOSEPH, M.M. TARPEY et al. 1995. S-Nitrosoglutathione improves functional recovery in the isolated rat heart following cardioplegic ischemic arrest-evidence for a cardioprotective effect of nitric oxide. J. Pharmacol. Exp. Ther. 274: 200-206.
13. 13. PABLA, R., A.J. BUDA, D.M. FLYNN et al. 1996. Nitric oxide attenuates neutrophil-mediated myocardial contractile dysfunction after ischemia and reperfusion. Circ. Res. 78: 65-72.
14. 14. ROSSONI, G., Y. BERTI, M. BERNAREGGI et al. 1995. Protective effects of ITF296 in the isolated rabbit heart subjected to global ischemia. J. Cardiovasc. Pharmacol. 26: S44-S52.
15. ATP channel. Circulation 95: 1278-1285.
16. 16. LANGENDORFF, O. 1895. Untersuchungen am uberlebenden Saugenierherzen. Pflugers Arch. Gesamte Physiol. 61: 291-332.
17. 17. BAKER, J.E., L.E. BOERBOOM, G.N. OLINGER et al. 1988. Age related changes in the ability of hypothermia and cardioplegia to protect ischemic rabbit myocardium. J. Thorac. Cardiovasc. Surg. 96: 717-724.
18. 18. KREBS, H.A. & K. HENSELEIT. 1932. Untersuchungen uber die Harnstoffbildung im Tierkorper. Hoppe Seylers Z. Physiol. Chem. 210: 33-66.
19. 19. LUDBROOK, J. 1994. Repeated measurements and multiple comparisons in cardiovascular research. Cardiovasc. Res. 28: 303-311.
20. 2) as internal standard. Biol. Mass. Spectrom. 21: 97-102.
21. 3 in plasma after experimental myocardial infarction. J. Mol. Cell Cardiol. 29: 1-9.
22. 22. PRATT, P.F., K. NITHIPATIKOM & W.B. CAMPBELL. 1995. Simultaneous determination of nitrate and nitrite in biological samples by multichannel flow injection analysis. Anal. Biochem. 231: 383-386.
23. 23. BALLIGAND, J.L., D. UNGUREANU, R.A. KELLY et al. 1993. Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. J. Clin. Invest. 91: 2314-2319.
24. 24. KONOREV, E.A., J. JOSEPH, M.M. TARPEY et al. 1996. The mechanism of cardioprotection by S-nitrosoglutathione monoethyl ester in rat heart during cardioplegic ischemic arrest. Br. J. Pharmacol. 119: 511-518.
25. 25. SESSA, W.C., K. PRITCHARD, N. SEYEDI, et al. 1994. Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression. Circ. Res. 74: 349-353.
26. 26. NARAYANAN, K., L. SPACK, K. MCMILLAN et al. 1995. S-alkyl-L-thiocitrullines. Potent stereoselective inhibitors of nitric oxide synthase with strong pressor activity in vivo. J. Biol. Chem. 270: 11103-11110.
27. 27. PLUNKETT, M.D., P.J. HENDRY, M.P. ANSTADT et al. 1996. Chronic hypoxia induces adaptive metabolic changes in neonatal myocardium. J. Thorac. Cardiovasc. Surg. 712: 8-13.
28. 28. KIRKLIN, J.W. & B.C. BARRATT-BOYES. 1993. Cardiac Surgery: 609-1596. Churchill Livingston Inc. New York.
29. 29. ZHAO, L., P.A. WEBER, J.R. SMITH et al. 1997. Role of inducible nitric oxide synthase in pharmacological "preconditioning" with monophosphoryl lipid A. J. Mol. Cell. Cardiol. 29: 1567-1576.
30. 30. ARNETT, O., A. MCMILLAN, J.L. DINERMAN et al. 1996. Regulation of endothelial nitric-oxide synthase during hypoxia. J. Biol. Chem. 271: 15069-15073.
31. 31. PABLA, R. & M.J. CURTIS. 1995. Effects of NO modulation on cardiac arrhythmias in the rat isolated heart. Circ. Res. 77: 984-992.
32. ATP channel activation in a rabbit model of chronic myocardial hypoxia. J. Mol. Cell Cardiol. 29: 845-848.
33. + channel openers in guinea-pig ventricular cells. Br. J. Pharmacol. 120: 1568-1574.
34. 34. MURPHY, M.E. & J.E. BRAYDEN. 1995. Nitric oxide hyperpolarizes rabbit mesenteric arteries via ATP-sensitive potassium channels. J. Physiol. 486: 47-58.
35. 35. NADAUD, S., M. PHILIPPE, J.-F. ARNAL et al. 1996. Sustained increase in aortic endothelial nitric oxide synthase expression in vivo in a model of chronic high blood flow. Circ. Res. 79: 857-863.
36. 36. NISHIDA, K., D.G. HARRISON, J.P. NAVAS et al. 1992. Molecular cloning and characterization of the consitutive bovine aortic endothelial cell nitric oxide synthase. J. Clin. Invest. 90: 2092-2096.
37. 37. UEMATSU, M., Y. OHARA, J.P. NAVAS et al. 1995. Regulation of endothelial cell nitric oxide synthase mRNA expression by shear stress. Am. J. Physiol. 289: C1371-C1378.
38. 38. NORIS, M., M. MORIGI, R. DONODELLI et al. 1995. Nitric oxide synthesis by cultured endothelial cells is modulated by flow conditions. Circ. Res. 76: 536-543.